University Of Miami School Of Medicine
- Image
University of Miami
The mission of the Miami Clinical and Translational Science Institute (CTSI) is to serve as the home to clinical and translational science at the University of Miami with the goals of: 1) Improving the quality and efficacy of clinical and translational research; 2) Advancing team science, and; 3) Culturalizing health sciences.
-University Of Miami School Of MedicineSoutheast Florida is a lighthouse for people living with spinal cord injury (SCI), and also a locus of risk for climate hazards such as hurricanes and flooding. An understanding of climate hazard needs and experiences in people with SCI can inform solutions that, if fit to the needs of this community, will readily scale laterally and vertically. This presentation will discuss the results of a
January 11, 2022It is with great pleasure that the Miami Clinical and Translational Science Institute (CTSI) announces that Olveen Carrasquillo, M.D, M.P.H., and Erin Kobetz, Ph.D., M.P.H., will join Director Ralph Sacco, M.D., M.S. and its leadership team as new co-directors. The Miami CTSI’s leadership team will evolve into a multiple principal investigator model with these three distinguished leaders.
Balancing Research and Commercialization: Opportunities and Challenges for the Academic Entrepreneur
-University Of Miami School Of MedicineJoin U Innovation at the University of Miami for its Concept to Commercialization Seminar Series featuring Dr. Suhrud Rajguru. Dr. Rajguru is Co-Director of the Miami CTSI's Translational Workforce Development Program, Assistant Director of the Collaboration and Multidisciplinary Team Science Program, and Co-Founder and Chief Scientific Officer at Restor-Ear, LL.
-University Of Miami School Of MedicineThe JANUS program supported by the Miami Clinical and Translational Science Institute aims to counter the effects of structural racism that lead to limited exposure of Black high-school students to careers in STEM, and Black Undergraduate students to (often unpaid) research opportunities. We expect that through the example and efforts of JANUS fellows, who are now ‘graduating’, diversity, equity- University Of Miami School Of Medicine
The dissemination of the I-Corps@NCATS program has accelerated the development and commercialization of breakthrough innovations in medical research across U. Miami and the CTSA partner hubs. Taking the lessons from the “I-Corps at the CTSA Train-The-Trainer pilot initiative” in 2017, nine participants developed the I-Corps@NCATS program with support from a CTSA Administrative Supplement to
August 17, 2021On July 8, the Miami Clinical and Translational Science Institute (CTSI), in collaboration with other University of Miami offices, hosted a webinar, “Recruitment & Retention Strategies for Underrepresented Minorities in Research,” focused on practical means of meeting participation goals.
August 17, 2021Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle-aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of U.S. Hispanic/Latinos to date.
August 17, 2021With proper business development tools and insights into entrepreneurship, biomedical researchers can improve the potential of their discoveries in the laboratory reaching patients. I-Corps@NCATS, a University of Miami (UM) Clinical and Translational Science Institute (CTSI) program, helps entrepreneurial-minded researchers move their new drugs, diagnostics, technologies, and devices forward to the next stage of development.-
July 01, 2021Alberto Ramos, M.D., M.S.P.H., Associate Professor of Neurology, CTSI KL2 Graduate, and Research Director of the Sleep Disorders Program at the University of Miami Miller School of Medicine, was awarded a five-year $13 million grant from the National Institute on Aging to study the impact of obstructive sleep apnea on the risk of Alzheimer’s disease and other dementias in Hispanic adults.
July 01, 2021Vitamin C, an essential dietary nutrient for humans, has been touted for its immune boosting properties for more than half a century. More recently, research has revealed its greater potential as a treatment for blood cancers. In her ongoing research, Miami CTSI Pilot Award recipient and Principal Investigator Luisa Cimmino, Ph.D., explores the potential of Vitamin C to combat blood cancers such as leukemia.
-University Of Miami School Of MedicineOn July 8 from 1 to 2 p.m., as The Miami Clinical and Translational Science Institute (CTSI) will host four Principal Investigators from the University of Miami for a virtual presentation to discuss the challenges and barriers as well as the strategies and best practices for recruiting underrepresented minorities into their various clinical research studies.
-University Of Miami School Of MedicineKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Chandylen Nightingale, PhD, MPH from the Wake Forest School of Medicine, hosted by the University of Miami School of Medicine will present her research on “Examining Capacity in Community Oncology and Moving the Needle to Improve Supportive Care Delivery for
Focal and Segmental Glomerulosclerosis, Minimal Change Disease, and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in
Myasthenia gravis (MG) is an autoimmune disease that blocks the signal from nerve to muscle, producing weakness. The nature of the disease can range from isolated severe vision problems, like drooping eyelids or double vision, to profound general weakness leading to breathing muscle failure. Although the cause of MG is not known, the disease appears to vary based on several factors, including the
Charcot-Marie-Tooth disease (CMT) is one of the most common inherited neurological disorders, affecting approximately 1 in 2,500 people in the United States. CMT, also known as hereditary motor and sensory neuropathy or peroneal muscular atrophy, comprises a group of disorders that affect peripheral nerves. The Inherited Neuropathy Consortium (INC) is a network of researchers working to find the
Amyotrophic lateral sclerosis (ALS) is a fatal disease that involves progressive death of motor nerves in the brain, brainstem, and spinal cord. The disease is closely related to disorders such as primary lateral sclerosis, hereditary spastic paraplegia, progressive muscular atrophy, and frontotemporal dementia. These diseases have shared genetic causes and underlying biology as well as a shared
University Of Miami School Of MedicineThe COVID-19 pandemic, while a significant disruptive event for research, resulted in a novel focus area for clinical and translational (C/T) researchers. Miami CTSI rapidly responded to this critical need by leading a collaborative effort to facilitate COVID-19 research and education initiatives for researchers and community stakeholders, while implementing innovative solutions to continue other
University Of Miami School Of MedicineThe COVID-19 pandemic, while a significant disruptive event for research, resulted in a novel focus area for clinical and translational (C/T) researchers. Miami CTSI rapidly responded to this critical need by leading a collaborative effort to facilitate COVID-19 research and education initiatives for researchers and community stakeholders, while implementing innovative solutions to continue other
July 21, 2020One of the first synergy papers supported by the CLIC and CTSA consortium was published in the Journal of Clinical and Translational Science. Abstract: A primary barrier to translation of clinical research discoveries into care delivery and population health is the lack of sustainable infrastructure bringing researchers, policymakers, practitioners, and communities together to reduce silos in
University Of North Carolina Chapel HillUniversity Of Miami School Of MedicineVirginia Commonwealth UniversityReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices.
-
-University Of Miami School Of Medicine
Please join the University of Miami CTSI for its next Translational Tuesday webinar, a weekly webinar series highlighting UM's top ongoing research and innovations for COVID-19. This webinar will feature a virtual presentation and Q&A with Dr. Natasa Strbo, who will provide a timely overview on efforts to develop a vaccine for the 2019 novel coronavirus SARS-CoV-2, the causative agent of
-University Of Miami School Of MedicinePlease join us on April 14 at 10 a.m., for Miami CTSI's Translational Tuesday, an online presentation and Q&A with Dr. Erin Kobetz and Dr. Natasha Schaefer Solle, of the University of Miami, who will discuss a new testing effort in collaboration with Miami-Dade County to assess the prevalence of COVID-19 infection in the local community.
The OneFlorida Clinical Research Consortium represents a strategic integration and expansion of CTSA hub partnerships throughout Florida to create a statewide infrastructure for patient-centered research in diverse health care settings. Consortium partners include the University of Florida, Florida State University, University of Miami and affiliated health care systems, health plans, providers
-
University Of North Carolina Chapel HillDuke UniversityWake Forest University Health SciencesMedical University Of South CarolinaUniversity Of Miami School Of MedicineVirginia Commonwealth UniversityReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices. Investigational New Drug or Biologic Investigational Device Exemption Educational Videos ReGARDD Sponsored Events Who We Are The Regulatory Guidance for Academic Research of Drugs and
The Division of Epidemiology in the Department of Public Health Sciences at the University of Miami is seeking an exceptional candidate for a full-time Associate/Full Professor position who will develop and consolidate a University-wide program in the Epidemiology of Non Communicable Diseases (NCD), in alignment with the Miller School of Medicine research strategic priorities, taking advantage of the intellectual capital throughout the University that addresses the unique diversity of our populations and South Florida's unique location as the gateway to Latin America and the Caribbean.
